2021
DOI: 10.1039/d0ra06099b
|View full text |Cite
|
Sign up to set email alerts
|

Identification and enhancing production of a novel macrolide compound in engineeredStreptomyces peucetius

Abstract: Activation of peucemycin in S. peucetius DM07 by the OSMAC strategy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 51 publications
0
6
0
Order By: Relevance
“…S3 . Compared to the structure of peucemycin (Pham et al 2021 ), a chemical shift (δ C ) of C-19 from 21.24 ppm of peucemycin to 62.89 ppm of peucemycin B was found. Similarly, a chemical shift (δ C ) of C-20 from 14.01 ppm of peucemycin to 24.35 ppm of peucemycin B was found.…”
Section: Resultsmentioning
confidence: 69%
See 3 more Smart Citations
“…S3 . Compared to the structure of peucemycin (Pham et al 2021 ), a chemical shift (δ C ) of C-19 from 21.24 ppm of peucemycin to 62.89 ppm of peucemycin B was found. Similarly, a chemical shift (δ C ) of C-20 from 14.01 ppm of peucemycin to 24.35 ppm of peucemycin B was found.…”
Section: Resultsmentioning
confidence: 69%
“…These findings led to the conclusion that the newly discovered compound was hydroxylated peucemycin. Furthermore, the compound had absorbance maxima of 200.7346, 215.7346, and 265.7347 nm similar to peucemycin and peucemycin A (Magar et al 2023 ; Pham et al 2021 ) (Fig. 1 ).…”
Section: Resultsmentioning
confidence: 70%
See 2 more Smart Citations
“…15 Doxorubicin from S. peucetius induces oxidative stress by releasing reactive oxygen species, thereby damaging DNA and triggering apoptosis in cancer cells. 16 Maculosin, a promising antioxidant molecule produced by Streptomyces sp. KTM 18, is used to treat deoxygenation in atherosclerosis, as well as neurodegenerative and inflammatory diseases.…”
mentioning
confidence: 99%